Details of the Drug Inactive Ingredient (DIG)

General Information of DIG (ID: E02WLG)
DIG Name
Aminoethanoic acid
Synonyms    Click to Show/Hide the Synonyms of This DIG
glycine; 2-Aminoacetic acid; 56-40-6; aminoacetic acid; Glycocoll; Aminoethanoic acid; Glycolixir; Padil; Glycosthene; Aciport; Glicoamin; L-Glycine; H-Gly-OH; Hampshire glycine; Amitone; Leimzucker; Acetic acid, amino-; Aminoazijnzuur; Glycine, non-medical; Sucre de gelatine; Gyn-hydralin; GLY (IUPAC abbrev); polyglycine; Glycinum; Corilin; Glycinum [INN-Latin]; Glicina [INN-Spanish]; Glycine [INN]; glycyl radical; Glyzin; FEMA No. 3287; gly; Acide aminoacetique [INN-French]; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum [INN-Latin]; CCRIS 5915; HSDB 495; AI3-04085; amino-Acetic acid; UNII-TE7660XO1C; MFCD00008131; NSC 25936; [14C]glycine; CHEMBL773; Glycine iron sulphate (1:1); TE7660XO1C; 25718-94-9; CHEBI:15428; 2-aminoaceticacid; AZD-4282; NSC25936; Athenon; NSC-25936; NCGC00024503-01; Glicina; DSSTox_CID_667; Glycine, free base; Polyglycine II; Acido aminoacetico; Acide aminoacetique; DSSTox_RID_75720; DSSTox_GSID_20667; Acidum aminoaceticum; Glycine, 99%, ACS reagent; Glycine, 99+%, for analysis; Glykokoll; Aminoessigsaeure; Hgly; CAS-56-40-6; Glycine, labeled with carbon-14; Glycine [USP:INN]; GLYCINE 1.5% IN PLASTIC CONTAINER; EINECS 200-272-2; H2N-CH2-COOH; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Glycine, homopolymer (VAN); Aminoethanoate; amino-Acetate; 2-aminoacetate; Glycine;; glycine USP; Glycine Technical; glycine-13c; [3H]glycine; Glycine, EP/USP; H-Gly; L-Gly; Gly-CO; Gly-OH; L-Glycine,(S); [14C]-glycine; Corilin (Salt/Mix); 112898-03-0; Glycine 1 M solution; PubChem18924; Tocris-0219; Glycine (H-Gly-OH); NH2CH2COOH; Glycine, >=99%; Glycine (JP17/USP); Glycine, 99%, FCC; Glycine-1,2-13C2; Biomol-NT_000195; bmse000089; bmse000977; WLN: Z1VQ; EC 200-272-2; H-[15N]Gly-OH; Gly-253; GTPL727; AB-131/40217813; GLYCINE, [2-3H]; Glycine, Electrophoresis Grade; BPBio1_001222; GTPL4084; GTPL4635; N[C]C(O)=O; DTXSID9020667; BDBM18133; Buffer Concentrate, pH 11.01; AZD4282; Glycine, >=99.0% (NT); Glycine, 98.5-101.5%; Pharmakon1600-01300021; 2-Aminoacetic acid;Aminoacetic acid; BCP25965; CS-B1641; HY-Y0966; ZINC4658552; Glycine, ACS reagent, >=98.5%; Tox21_113575; 2-amino-1-$l^{1}-oxidanylethanone; ANW-32505; Glycine, 99%, natural, FCC, FG; NSC760120; s4821; STL194276; Glycine, purum, >=98.5% (NT); Glycine, tested according to Ph.Eur.; AKOS000119626; Glycine, for electrophoresis, >=99%; Tox21_113575_1; AM81781; CCG-266010; DB00145; MCULE-2415764032; NSC-760120; Glycine, BioUltra, >=99.0% (NT); Glycine, BioXtra, >=99% (titration); Glycine, SAJ special grade, >=99.0%; NCGC00024503-02; NCGC00024503-03; 18875-39-3; AK-77854; BP-31024; Glycine, Vetec(TM) reagent grade, 98%; Glycine, 0.2M buffer solution, pH 2.5; Glycine, 0.2M buffer solution, pH 3.0; Glycine, 0.2M buffer solution, pH 3.5; DB-029870; FT-0600491; FT-0669038; G0099; G0317; Glycine, ReagentPlus(R), >=99% (HPLC); A20662; C00037; D00011; M-6155; M03001; L001246; Q620730; SR-01000597729; Glycine, certified reference material, TraceCERT(R); Q-201300; SR-01000597729-1; Q27115084; B72BA06C-60E9-4A83-A24A-A2D7F465BB65; F2191-0197; Glycine, European Pharmacopoeia (EP) Reference Standard; Z955123660; Glycine, BioUltra, for molecular biology, >=99.0% (NT); UNII-0O72R8RF8A component DHMQDGOQFOQNFH-UHFFFAOYSA-N; Glycine, United States Pharmacopeia (USP) Reference Standard; Glycine, Pharmaceutical Secondary Standard; Certified Reference Material; Tris-tricine buffer; Tris-glycine buffer;Tris glycine buffer concentrate; Glycine, analytical standard, for nitrogen determination according to Kjeldahl method; 21931-03-3; Glycine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, >=98.5%; Glycine, meets analytical specification of Ph. Eur., BP, USP, 99-101% (based on anhydrous substance); Glycine, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture; Glycine, puriss. p.a., Reag. Ph. Eur., buffer substance, 99.7-101% (calc. to the dried substance)
DIG Function
Buffering agent; Disintegrant; Lyophilization aid
PubChem CID
750
Formula
C2H5NO2
Canonical SMILES
C(C(=O)O)N
InChI
1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)
InChIKey
DHMQDGOQFOQNFH-UHFFFAOYSA-N
   Click to Show/Hide the Molecular Data (Structure/Property) of This DIG
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=750"></iframe>
3D MOL 2D MOL
Physicochemical Properties Molecular Weight 75.07 Topological Polar Surface Area 63.3
XlogP -3.2 Complexity 42.9
Heavy Atom Count 5 Rotatable Bond Count 1
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 3
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG
       ICD Disease Classification 05 Endocrine/nutritional/metabolic disease Click to Show/Hide
Chlorpropamide
 API Info
Diabetes mellitus [ICD-11: 5A10]
 [1]
       ICD Disease Classification 06 Mental/behavioural/neurodevelopmental disorder Click to Show/Hide
Risperidone
 API Info
Schizophrenia [ICD-11: 6A20]
 [2]
Fluoxetine
 API Info
Major depressive disorder [ICD-11: 6A70]
 [3]
Duloxetine
 API Info
Major depressive disorder [ICD-11: 6A70]
 [4]
       ICD Disease Classification 08 Nervous system disease Click to Show/Hide
Rizatriptan
 API Info
Migraine [ICD-11: 8A80]
 [5]
       ICD Disease Classification 15 Musculoskeletal/connective-tissue disease Click to Show/Hide
Cyclosporin A
 API Info
Rheumatoid arthritis [ICD-11: FA20]
 [6]
       ICD Disease Classification 16 Genitourinary system disease Click to Show/Hide
Dutasteride
 API Info
Prostatic hyperplasia [ICD-11: GA90]
 [7]
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG
      Lyase/isomerase/ligase (L/I/G)
            DBT Name: Serine racemase (SRR) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Biological Activity Ki = 366000 nM (tested by experiment) [8]
                    Tested Species Homo sapiens (Human)
                    UniProt ID SRR_HUMAN
      Potential-driven transporter (PDT)
            DBT Name: Glycine type-1 transporter (GlyT-1) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Biological Activity IC50 = 31600 nM (tested by experiment) [9]
                    Tested Species Homo sapiens (Human)
                    UniProt ID SC6A9_HUMAN
      Transmembrane channel/porin (TC/P)
            DBT Name: Glutamate receptor NMDA (GRIN) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Biological Activity Ki = 125.89 nM (tested by experiment) [10]
                    Tested Species Rattus norvegicus (Rat)
                    UniProt ID NMDZ1_RAT ; NMDE1_RAT ; NMDE2_RAT ; NMDE3_RAT ; NMDE4_RAT ; NMD3A_RAT ; NMD3B_RAT
            DBT Name: Glycine receptor alpha-1 (GLRA1) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Biological Activity EC50 = 94000 nM (tested by experiment) [11]
                    Tested Species Homo sapiens (Human)
                    UniProt ID GLRA1_HUMAN
References
1 FDA label for approved chlorpropamide from the official website of the U.S. Food and Drug Administration.
2 FDA label for approved risperidone from the official website of the U.S. Food and Drug Administration.
3 FDA label for approved fluoxetine from the official website of the U.S. Food and Drug Administration.
4 FDA label for approved duloxetine from the official website of the U.S. Food and Drug Administration.
5 FDA label for approved rizatriptan from the official website of the U.S. Food and Drug Administration.
6 FDA label for approved cyclosporin A from the official website of the U.S. Food and Drug Administration.
7 FDA label for approved dutasteride from the official website of the U.S. Food and Drug Administration.
8 In silico and pharmacological screenings identify novel serine racemase inhibitors. Bioorg Med Chem Lett. 2014 Aug 15; 24(16):3732-5.
9 Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: development of a potent and CNS penetrant [3.1.0]-based lead. Bioorg Med Chem Lett. 2014 Feb 15; 24(4):1067-70.
10 Drug design, in vitro pharmacology, and structure-activity relationships of 3-acylamino-2-aminopropionic acid derivatives, a novel class of partial agonists at the glycine site on the N-methyl-D-aspartate (NMDA) receptor complex. J Med Chem. 2009 Aug 27; 52(16):5093-107.
11 Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor. J Med Chem. 2007 Sep 20; 50(19):4616-29.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.